14:00 | Proven ophthalmological manifestation during COVID-19 disease | KOZYREFF A | ||
14:07 | Ocular surface and COVID-19 (including receptor expression, eye banking, gene expression from cornea, allergy and dry eye) | LEONARDI A | ||
14:14 | Possible ophthalmological manifestation of COVID-19 | VAN CALSTER J | ||
14:21 | Retinal involvement in COVID-19 | INVERNIZZI A | ||
14:28 | Impact of COVID 19 on the management of uveitis patients | TESTI I | ||
14:35 | Can COVID 19 vaccines induce ocular manifestations | WILLERMAIN F | ||
14:42 | Q & A | |||
14:45 | End of Session |